Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2019-05-17

DOI

10.1016/s0140-6736(19)30654-3

Contact the author

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started